Halozyme Therapeutics, Inc. announced the appointment of David Ramsay as President Drug Delivery, effective June 30, 2026.
In this newly created role, Mr. Ramsay will...
ATB Therapeutics a biopharmaceutical company advancing next-generation antibody-based therapies for oncology and immunology, announced the appointment of Mark Throsby, PhD, as Chief Executive Officer. The...
The biopharmaceutical industry is currently facing a "productivity paradox." This involves having access to unprecedented amounts of data such as electronic health records and...
CPC Biotech, part of PSG and Dover and a leading manufacturer of connectors, pumps, and flow sensors used in biopharmaceutical processing, announced the launch of the AseptiQuik® G...
Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to treating MASH, obesity, and associated cardiometabolic diseases, announced the appointment of Jorge Bartolome as Chief...
